Trial
NCT04978493
A Study to Test Whether BI 706321 Combined With Ustekinumab Helps People With Crohn's Disease
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Boehringer Ingelheim
Collaborators
—
Condition
Crohn Disease
Intervention
BI 706321
Why stopped
Company decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-09-04